Unknown

Dataset Information

0

The novel rexinoid MSU-42011 is effective for the treatment of preclinical Kras-driven lung cancer


ABSTRACT: Effective drugs are needed for lung cancer, as this disease remains the leading cause of cancer-related deaths. Rexinoids are promising drug candidates for cancer therapy because of their ability to modulate genes involved in inflammation, cell proliferation or differentiation, and apoptosis through activation of the retinoid X receptor (RXR). The only currently FDA-approved rexinoid, bexarotene, is ineffective as a single agent for treating epithelial cancers and induces hypertriglyceridemia. Here, we used a previously validated screening paradigm to evaluate 23 novel rexinoids for biomarkers related to efficacy and safety. These biomarkers include suppression of inducible nitric oxide synthase (iNOS) and induction of sterol regulatory element-binding protein (SREBP). Because of its potent iNOS suppression, low SREBP induction, and activation of RXR, MSU-42011 was selected as our lead compound. We next used MSU-42011 to treat established tumors in a clinically relevant Kras-driven mouse model of lung cancer. KRAS is one of the most common driver mutations in human lung cancer and correlates with aggressive disease progression and poor patient prognosis. Ultrasound imaging was used to detect and monitor tumor development and growth over time in the lungs of the A/J mice. MSU-42011 markedly decreased the tumor number, size, and histopathology of lung tumors compared to the control and bexarotene groups. Histological sections of lung tumors in mice treated with MSU-42011 exhibited reduced cell density and fewer actively proliferating cells compared to the control and bexarotene-treated tumors. Although bexarotene significantly (p?

SUBMITTER: Moerland J 

PROVIDER: S-EPMC7746742 | biostudies-literature | 2020 Jan

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC8508021 | biostudies-literature
| S-EPMC8742020 | biostudies-literature
| S-EPMC4701567 | biostudies-literature
| S-EPMC6049313 | biostudies-literature
| S-EPMC6721568 | biostudies-literature
| S-EPMC9487658 | biostudies-literature
| S-EPMC7352727 | biostudies-literature
| S-EPMC6279402 | biostudies-literature
| S-EPMC7442594 | biostudies-literature
| S-EPMC6328329 | biostudies-literature